Aris Wijayanto - Central Proteina Director of Human Capital and General Affairs
CPRO Stock | IDR 51.00 1.00 2.00% |
Director
Mr. Aris Wijayanto serves as Director of Human Capital and General Affairs of PT Central Proteina Prima Tbk since June 1, 2012. He holds Bachelor degree from Universitas Sebelas Maret, Indonesia, in 1983, MS from Indiana University, USA, in 1989 and MBA from Monash University, Australia . He also holds a doctoral degree from Bogor Agricultural University in 2012. He worked as a Director of ICI Akzo, Nestle and Nabisco Food. He also served as Training Manager in Indofood Sukses Makmur and Researcher in Department of National Education before joining CP Prima. since 2012.
Age | 63 |
Tenure | 12 years |
Professional Marks | MBA |
Phone | 62 21 5019 1788 |
Web | https://www.cpp.co.id |
Central Proteina Management Efficiency
The company has return on total asset (ROA) of 0.0811 % which means that it generated a profit of $0.0811 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.127 %, meaning that it generated $0.127 on every $100 dollars invested by stockholders. Central Proteina's management efficiency ratios could be used to measure how well Central Proteina manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 1.06 T in total debt. Central Proteina Prima has a current ratio of 0.32, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Central Proteina until it has trouble settling it off, either with new capital or with free cash flow. So, Central Proteina's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Central Proteina Prima sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Central to invest in growth at high rates of return. When we think about Central Proteina's use of debt, we should always consider it together with cash and equity.
PT Central Proteina Prima Tbk, together with its subsidiaries, operates as an integrated aquaculture company in Indonesia and internationally. PT Central Proteina Prima Tbk was founded in 1980 and is headquartered in Jakarta Selatan, Indonesia. Central Proteina operates under Farm Products classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1780 people. Central Proteina Prima (CPRO) is traded on Jakarta Exchange in Indonesia and employs 1,783 people. Management Performance
Return On Equity | 0.13 | |||
Return On Asset | 0.0811 |
Central Proteina Prima Leadership Team
Elected by the shareholders, the Central Proteina's board of directors comprises two types of representatives: Central Proteina inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Central. The board's role is to monitor Central Proteina's management team and ensure that shareholders' interests are well served. Central Proteina's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Central Proteina's outside directors are responsible for providing unbiased perspectives on the board's policies.
Eko Sandjojo, Independent Commissioner | ||
Sidarta Sidik, Director of Food Product Marketing | ||
Tobias Damek, Commissioner | ||
Arianto Yohan, Independent Director | ||
Hendri Laiman, Pres Director | ||
Djoko Basoeki, Independent Commissioner | ||
M Joeng, Vice President Director | ||
Armand Ardika, Corporate Secretary | ||
Franciscus Affandy, Vice President Commissioner | ||
Mahar Sembiring, President Director | ||
Toto Winanto, Independent Commissioner | ||
Sutanto Surjadjaja, Director | ||
Aris Wijayanto, Director of Human Capital and General Affairs | ||
Emmanuel Ramli, Director | ||
Christopher Nacson, Commissioner | ||
Saleh Yu, Vice President Director | ||
Ilphin Wunardi, Head Division | ||
Irwan Tirtariyadi, President Director | ||
Fachrul Razi, President Commissioner, Independent Commissioner | ||
Achmad Wahyudi, Unaffiliated Director | ||
Isman Hariyanto, Director | ||
Fredy Sumendap, Director | ||
Saleh, Director |
Central Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Central Proteina a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.13 | |||
Return On Asset | 0.0811 | |||
Profit Margin | 0.05 % | |||
Operating Margin | 0.11 % | |||
Current Valuation | 5.48 T | |||
Shares Outstanding | 40.47 B | |||
Shares Owned By Insiders | 48.75 % | |||
Price To Book | 1.02 X | |||
Price To Sales | 0.39 X | |||
Revenue | 8.03 T |
Pair Trading with Central Proteina
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Central Proteina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Central Proteina will appreciate offsetting losses from the drop in the long position's value.Moving together with Central Stock
0.61 | BBRI | Bank Rakyat Indonesia | PairCorr |
Moving against Central Stock
0.45 | HMSP | Hanjaya Mandala Sampoerna Earnings Call Next Week | PairCorr |
0.43 | UNVR | Unilever Indonesia Tbk | PairCorr |
The ability to find closely correlated positions to Central Proteina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Central Proteina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Central Proteina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Central Proteina Prima to buy it.
The correlation of Central Proteina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Central Proteina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Central Proteina Prima moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Central Proteina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Central Stock analysis
When running Central Proteina's price analysis, check to measure Central Proteina's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Central Proteina is operating at the current time. Most of Central Proteina's value examination focuses on studying past and present price action to predict the probability of Central Proteina's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Central Proteina's price. Additionally, you may evaluate how the addition of Central Proteina to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |